Another company joined the portfolio of our partner Carlson EVIG Alfa VC Fund. This time it is Nutrix, a Swiss medical technology startup that focuses on the development of software and artificial intelligence algorithms that help in monitoring glucose present in saliva and treating diabetes. easy, non-invasive and painless way. We are convinced that with the support of Carlson EVIG Alfa VC Fund Nutrix will achieve its goals in a short time. https://nutrix.tech/